INTRODUCTION – The Protection of Critical Infrastructures (Computer Systems) Bill (the “Bill”), as the first law in Hong Kong to…
Read More →
Supply chain disruptions have become a significant challenge for the U.S. FDA-regulated products industry, affecting the availability of pharmaceuticals, medical…
Read More →
On July 23, 2025, the White House released Winning the AI Race: America’s AI Action Plan pursuant to Executive Order 14179 (January 23, 2025, “Removing…
Read More →
Establish a compliance framework to innovate confidently and avoid regulatory missteps. Use testing licenses and sandbox environments to trial new…
Read More →
As the Trump administration rolls out its AI Action Plan, which we will separately cover in depth in the next…
Read More →
Earlier this week, President Trump signed an Executive Order as part of the release of his AI Action Plan entitled…
Read More →
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due…
Read More →
In a previous JD Supra article, I wrote about the Sixth Circuit Court’s initial decision, which upheld class certification for…
Read More →
The American Tort Reform Foundation’s list of “Judicial Hellholes” often are all-too-familiar jurisdictions for product liability defendants. Some states who…
Read More →
Defective medical devices can present serious—and sometimes life-threatening—risks for patients. As a patient, you never expect a medical implant to…
Read More →